DUGGAN ROBERT W 4

4 · PULSE BIOSCIENCES, INC. · Filed May 11, 2026

AI-generated summary of this filing

Updated May 11, 2026

Pulse Biosciences (PLSE) 10% Owner Robert Duggan Buys Stock

What Happened

Robert W. Duggan, reported as a 10% owner of Pulse Biosciences (PLSE), purchased 660,233 shares on May 11, 2026 at $19.69 per share for a total of $12,999,988. The transaction is coded P (purchase) and was executed through the company's at‑the‑market (ATM) equity offering.

Key Details

Transaction date and price: May 11, 2026 — 660,233 shares at $19.69 each (total $12,999,988).
Method: Acquired through Pulse’s ATM equity offering under an Equity Distribution Agreement with TD Securities (USA) LLC; shares purchased at prevailing market bid price or better (footnotes F1, F2).
Holdings: Shares are held by entities Genius 24C Inc. and Blazon Corporation, of which Duggan is the sole shareholder (footnotes F3, F4).
Insider status / timing: Reporting person is a 10% owner (noted in the filing). Purchase occurred during an open trading window and was reported the same day (no late filing indicated).

Context

This is a direct purchase of common stock via the company’s ATM program (a common way companies raise equity). Purchases by insiders can be seen as a bullish signal, but they do not by themselves explain the buyer’s motives. The filing shows the shares were bought through the company’s distribution program rather than via a private transfer or option exercise.

Form 4

Period: 2026-05-11

Director10% Owner

Transactions

Purchase
Common Stock
[F1][F2]
2026-05-11$19.69/sh+660,233$12,999,988→ 48,211,433 total

Holdings

Footnotes (4)

[F1]The shares reported herein were acquired through the Company's at-the-market equity offering program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026, by and between the Company and TD Securities (USA) LLC, as sales agent. The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws.
[F2]The shares reported herein were acquired through the Company's at-the-market equity offering program at the prevailing market bid price or better at the time of sale.
[F3]Shares are held by Genius 24C Inc., of which the Reporting Person is the sole shareholder.
[F4]Shares are held by Blazon Corporation, of which the Reporting Person is the sole shareholder.

Signature

/s/ Kenneth B. Stratton, as Attorney-in-Fact|2026-05-11

1 file